8 Results for "

selexipag

" in MedChemExpress (MCE) Product Catalog:
Products (8)

8 Results for "selexipag" in MCE Product Catalog:

3
3 Cited Publications
Cat. No.: HY-14870
CAS No.: 475086-01-2
Purity:  99.86%
Synonyms: NS-304; ACT-293987
Selexipag (NS-304) is an orally available and potent agonist for the Prostacyclin (PGI2) receptor (IP receptor).
loading...
    loading...
1
1 Cited Publications
Cat. No.: HY-79593
CAS No.: 475085-57-5
Synonyms: ACT-333679
MRE-269 is an active metabolite of selexipag, and acts as a selective IP receptor agonist.
loading...
    loading...
Cat. No.: HY-14870S1
CAS No.: 1265295-21-3
Purity:  98.44%
Selexipag-d7 is the deuterium labeled Selexipag. Selexipag (NS-304) is an orally available and potent agonist for the Prostacyclin (PGI2) receptor (IP receptor) .
loading...
    loading...
Cat. No.: HY-14870S3
CAS No.: 1265295-92-8
Synonyms: NS-304-d6; ACT-293987-d6
Selexipag-d6 is deuterium labeled Selexipag. Selexipag (NS-304) is an orally available and potent agonist for the Prostacyclin (PGI2) receptor (IP receptor).
loading...
    loading...
Cat. No.: HY-79593S1
CAS No.: 1265295-56-4
Synonyms: ACT-333679-d6
MRE-269-d6 is deuterium labeled MRE-269. MRE-269 is an active metabolite of selexipag, and acts as a selective IP receptor agonist.
loading...
    loading...
Cat. No.: HY-14870R
CAS No.: 475086-01-2
Synonyms: NS-304 (Standard); ACT-293987 (Standard)
Selexipag (Standard) is the analytical standard of Selexipag. This product is intended for research and analytical applications. Selexipag (NS-304) is an orally available and potent agonist for the Prostacyclin (PGI2) receptor (IP receptor).
loading...
    loading...
Cat. No.: HY-79593S2
CAS No.: 1265295-20-2
Synonyms: ACT-333679-d7
MRE-269-d7 is deuterium labeled MRE-269 (HY-79593). MRE-269 is an active metabolite of selexipag, and acts as a selective IP receptor agonist .
loading...
    loading...
Cat. No.: HY-79593R
CAS No.: 475085-57-5
Synonyms: ACT-333679 (Standard)
MRE-269 (Standard) is the analytical standard of MRE-269. This product is intended for research and analytical applications. MRE-269 is an active metabolite of selexipag, and acts as a selective IP receptor agonist.
loading...
    loading...